Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens

Clinical trial NCT01721759 · COMPLETED

Trial details

NCT number

NCT01721759

Sponsor

Bristol-Myers Squibb

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2012-11-16

Primary completion

2014-01-22

Enrollment

117

View on ClinicalTrials.gov